“Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024049. doi:10.4084/MJHID.2024.049.